• 1
    Moffett-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2:656663.
  • 2
    LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED: HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+  T cells. Proc Natl Acad Sci U S A 2004; 101:70647069.
  • 3
    Hunt JS, Petroff MG, McIntire RH, Ober C: HLA-G and immune tolerance in pregnancy. FASEB J 2005; 19:681693.
  • 4
    Robinson J, Waller MJ, Parham P, Bontrop R, Kennedy LJ, Stoehr P, Marsh SG: IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 2003; 31:311314.
  • 5
    Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG, Martin PJ, Hansen JA: Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997; 89:18181823.
  • 6
    Heemskerk MB, Roelen DL, Dankers MK, van Rood JJ, Claas FH, Doxiadis II, Oudshoorn M: Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. Hum Immunol 2005; 66:969976.
  • 7
    Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg V, Roelen DL, van Rood JJ, Claas FH: Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol 2009; 82:148157.
  • 8
    Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA, Claas FH: Evidence for a Selective Migration of Fetus-Specific CD4 + CD25bright Regulatory T Cells from the Peripheral Blood to the Decidua in Human Pregnancy. J Immunol 2008; 180:57375745.
  • 9
    Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266271.
  • 10
    Tilburgs T, Schonkeren D, Eikmans M, Nagtzaam NM, Datema G, Swings GM, Prins F, van Lith JM, van der Mast BJ, Roelen DL, Scherjon SA, Claas FH: Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J Immunol 2010; 185:44704477.
  • 11
    van Kampen CA, Versteeg-van der Voort Maarschalk MF, Langerak-Langerak J, van Beelen E, Roelen DL, Claas FH: Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol 2001; 62:201207.
  • 12
    Verdijk RM, Kloosterman A, Pool J, van de KM, Naipal AM, van Halteren AG, Brand A, Mutis T, Goulmy E: Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004; 103:19611964.
  • 13
    Ahmed R, Gray D: Immunological memory and protective immunity: understanding their relation. Science 1996; 272:5460.
  • 14
    Lanzavecchia A, Sallusto F: Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290:9297.
  • 15
    van Lier RA, ten Berge IJ, Gamadia LE: Human CD8(+) T cell differentiation in response to viruses. Nat Rev Immunol 2003; 3:931939.
  • 16
    Mueller SN, Gebhardt T, Carbone FR, Heath WR: Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 2012; Dec 3. [Epub ahead of print].
  • 17
    Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708712.
  • 18
    Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745763.
  • 19
    Sallusto F, Mackay CR, Lanzavecchia A: The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000; 18:593620.
  • 20
    Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM, Corthesy P, Devevre E, Speiser EM, Rufer N: Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 2007; 178:41124119.
  • 21
    Mueller SN, Germain RN: Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 2009; 9:618629.
  • 22
    Siegert S, Luther SA: Positive and negative regulation of T cell responses by fibroblastic reticular cells within paracortical regions of lymph nodes. Front Immunol 2012; 3:285.
  • 23
    Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN: Chemokines enhance immunity by guiding naive CD8+  T cells to sites of CD4+  T cell-dendritic cell interaction. Nature 2006; 440:890895.
  • 24
    Hickman HD, Li L, Reynoso GV, Rubin EJ, Skon CN, Mays JW, Gibbs J, Schwartz O, Bennink JR, Yewdell JW: Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. J Exp Med 2011; 208:25112524.
  • 25
    Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK, Picker LJ, Butcher EC: The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991; 174:14611466.
  • 26
    Matsumoto M, Shigeta A, Furukawa Y, Tanaka T, Miyasaka M, Hirata T: CD43 collaborates with P-selectin glycoprotein ligand-1 to mediate E-selectin-dependent T cell migration into inflamed skin. J Immunol 2007; 178:24992506.
  • 27
    Tubo NJ, McLachlan JB, Campbell JJ: Chemokine receptor requirements for epidermal T cell trafficking. Am J Pathol 2011; 178:24962503.
  • 28
    Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bünemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A: CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8:157165.
  • 29
    Kallikourdis M, Andersen KG, Welch KA, Betz AG: Alloantigen-enhanced accumulation of CCR5 +  ‘effector’ regulatory T cells in the gravid uterus. Proc Natl Acad Sci U S A 2007; 104:594599.
  • 30
    Nancy P, Tagliani E, Tay CS, Asp P, Levy DE, Erlebacher A: Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 2012; 336:13171321.
  • 31
    Tilburgs T, Claas FH, Scherjon SA: Elsevier Trophoblast Research Award Lecture: unique properties of decidual T cells and their role in immune regulation during human pregnancy. Placenta 2010; 31(Suppl):S82S86.
  • 32
    Vassiliadou N, Bulmer JN: Quantitative analysis of T lymphocyte subsets in pregnant and nonpregnant human endometrium. Biol Reprod 1996; 55:10171022.
  • 33
    Tilburgs T, van der Mast BJ, Nagtzaam NM, Roelen DL, Scherjon SA, Claas FH: Expression of NK cell receptors on decidual T cells in human pregnancy. J Reprod Immunol 2009; 80:2232.
  • 34
    Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N: miRNA profiling of naive, effector and memory CD8 T cells. PLoS ONE 2007; 2:e1020.
  • 35
    Wu T, Wieland A, Araki K, et al.: Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+  T cell differentiation. Proc Natl Acad Sci U S A 2012; 109:99659970.
  • 36
    Scaife PJ, Bulmer JN, Robson SC, Innes BA, Searle RF: Effector activity of decidual CD8+  T lymphocytes in early human pregnancy. Biol Reprod 2006; 75:562567.
  • 37
    Rudolph MG, Wilson IA: The specificity of TCR/pMHC interaction. Curr Opin Immunol 2002; 14:5265.
  • 38
    Madden DR, Gorga JC, Strominger JL, Wiley DC: The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992; 70:10351048.
  • 39
    Chien YH, Davis MM: How alpha beta T cell receptors ‘see’ peptide/MHC complexes. Immunol Today 1993; 14:597602.
  • 40
    Gamadia LE, Remmerswaal EB, Surachno S, Lardy NM: Wertheim-van Dillen PM, van Lier RA, ten Berge IJ: Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules. Transplantation 2004; 77:18791885.
  • 41
    Amir AL, D'Orsogna LJ, Roelen DL, van Loenen MM, Hagedoorn RS, de BR, van der Hoorn MA, Kester MG, Doxiadis II , Falkenburg JH, Claas FH, Heemskerk MH: Allo-HLA reactivity of virus-specific memory T cells is common. Blood 2010; 115:31463157.
  • 42
    D'Orsogna LJ, Roelen DL, Doxiadis II, Claas FH: TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition. Immunogenetics 2012; 64:7785.
  • 43
    Madeja Z, Yadi H, Apps R, Boulenouar S, Roper SJ, Gardner L, Moffett A, Colucci F, Hemberger M: Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci U S A 2011; 108:40124017.
  • 44
    Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B: T cell awareness of paternal alloantigens during pregnancy. Science 1995; 270:630633.
  • 45
    Erlebacher A, Vencato D, Price KA, Zhang D, Glimcher LH: Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest 2007; 117:13991411.
  • 46
    Goulmy E: Human minor histocompatibility antigens. Curr Opin Immunol 1996; 8:7581.
  • 47
    Li C, Houser BL, Nicotra ML, Strominger JL: HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci U S A 2009; 106:57675772.
  • 48
    Houser BL, Tilburgs T, Hill J, Nicotra ML, Strominger JL: Two unique human decidual macrophage populations. J Immunol 2011; 186:26332642.
  • 49
    Goulmy E, Termijtelen A, Bradley BA, van Rood JJ: Alloimmunity to human H-Y. Lancet 1976; 2:1206.
  • 50
    Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E: Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999; 5:839842.
  • 51
    Spellman S, Warden MB, Haagenson M, Pietz BC, Goulmy E, Warren EH, Wang T, Ellis TM: Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplant 2009; 15:856863.
  • 52
    Holland OJ, Linscheid C, Hodes HC, Nauser TL, Gilliam M, Stone P, Chamley LW, Petroff MG: Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus. Am J Pathol 2012; 180:256266.
  • 53
    van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J, Brand A, Burlingham WJ, Goulmy E: Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 2009; 114:22632272.
  • 54
    Lissauer D, Piper K, Goodyear O, Kilby MD, Moss PA: Fetal-specific CD8+  cytotoxic T cell responses develop during normal human pregnancy and exhibit broad functional capacity. J Immunol 2012; 189:10721080.
  • 55
    Moldenhauer LM, Diener KR, Thring DM, Brown MP, Hayball JD, Robertson SA: Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol 2009; 182:80808093.
  • 56
    Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hil Jl, Davis E, Flanigan C, Cloud G: Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009; 360:11911199.
  • 57
    Rasmussen SA, Jamieson DJ, Uyeki TM: Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 2012; 207:S3S8.
  • 58
    Laibl VR, Sheffield JS: Influenza and pneumonia in pregnancy. Clin Perinatol 2005; 32:727738.
  • 59
    Guntupalli SR, Steingrub J: Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med 2005; 33:S332S339.
  • 60
    Kenneson A, Cannon MJ: Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17:253276.
  • 61
    Nigro G, Mazzocco M, Mattia E, Di Renzo GC, Carta G, Anceschi MM: Role of the infections in recurrent spontaneous abortion. J Matern Fetal Neonatal Med 2011; 24:983989.
  • 62
    Nigro G, Adler SP, Parruti G, Anceschi MM, Coclite E, Pezone I, Di Renzo GC: Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy–a case-control study of the outcome in children. J Infect Dis 2012; 205:215227.
  • 63
    Revello MG, Lilleri D, Zavattoni M, Furione M, Genini E, Comolli G, Gerna G: Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers. J Infect Dis 2006; 193:269276.
  • 64
    Lilleri D, Fornara C, Furione M, Zavattoni M, Revello MG, Gerna G: Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J Infect Dis 2007; 195:10621070.
  • 65
    Fornara C, Lilleri D, Revello MG, Furione M, Zavattoni M, Lenta E, Gerna G: Kinetics of effector functions and phenotype of virus-specific and gammadelta T lymphocytes in primary human cytomegalovirus infection during pregnancy. J Clin Immunol 2011; 31:10541064.
  • 66
    Lissauer D, Choudhary M, Pachnio A, Goodyear O, Moss PA, Kilby MD: Cytomegalovirus sero positivity dramatically alters the maternal CD8+  T cell repertoire and leads to the accumulation of highly differentiated memory cells during human pregnancy. Hum Reprod 2011; 26:33553365.
  • 67
    Constantin CM, Masopust D, Gourley T, Grayson J, Strickland OL, Ahmed R, Bonney EA: Normal establishment of virus-specific memory CD8 T cell pool following primary infection during pregnancy. J Immunol 2007; 179:43834389.
  • 68
    Park B, Spooner E, Houser BL, Strominger JL, Ploegh HL: The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med 2010; 207:20332041.
  • 69
    Loenen WA, Bruggeman CA, Wiertz EJ: Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin Immunol 2001; 13:4149.
  • 70
    Jun Y, Kim E, Jin M, Sung HC, Han H, Geraghty DE, Ahn K: Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J Immunol 2000; 164:805811.
  • 71
    Ljunggren HG, Karre K: In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990; 11:237244.
  • 72
    Schust DJ, Tortorella D, Ploegh HL: HLA-G and HLA-C at the feto-maternal interface: lessons learned from pathogenic viruses. Semin Cancer Biol 1999; 9:3746.
  • 73
    Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, Baltimore D: The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999; 10:661671.
  • 74
    Makadzange AT, Gillespie G, Dong T, Kiama P, Bwayo J, Kimani J, Plummer F, Easterbrook P, Rowland-Jones SL: Characterization of an HLA-C-restricted CTL response in chronic HIV infection. Eur J Immunol 2010; 40:10361041.
  • 75
    Joosten SA, van Meijgaarden KE, Savage ND, de Boer T, Triebel F, van der Wal WA, de Heer E, Klein MR, Geluk A, Ottenhoff TH: Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A 2007; 104:80298034.
  • 76
    Pietra G, Romagnani C, Mazzarino P, Falco M, Millo E, Moretta A, Moretta L, Mingari MC: HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci U S A 2003; 100:1089610901.
  • 77
    Jorgensen PB, Livbjerg AH, Hansen HJ, Petersen T, Hollsberg P: Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients. PLoS ONE 2012; 7:e46120.
  • 78
    Le BP, Siewiera J, Casart Y, Aguerre-Girr M, El CH, Berrebi A, Tabiasco J, Jabrane-Ferrat N: The human decidual NK-cell response to virus infection: what can we learn from circulating NK lymphocytes? J Reprod Immunol 2011; 88:170175.
  • 79
    Xu X, Fu Q, Zhang Q, Zhao M, Gao Z, Liu X, Liu Y, Hu X: Changes of human decidual natural killer cells cocultured with YFP-Toxoplasma gondii: implications for abnormal pregnancy. Fertil Steril 2012; 99:427432.
  • 80
    Mellor AL, Munn DH: IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4:762774.
  • 81
    Petroff MG, Chen L, Phillips TA, Hunt JS: B7 family molecules: novel immunomodulators at the maternal-fetal interface. Placenta 2002; 23(Suppl A):S95S101.
  • 82
    Petroff MG, Kharatyan E, Torry DS, Holets L: The immunomodulatory proteins B7-DC, B7–H2, and B7–H3 are differentially expressed across gestation in the human placenta. Am J Pathol 2005; 167:465473.
  • 83
    Rubtsov YP, Rudensky AY: TGFbeta signalling in control of T cell-mediated self-reactivity. Nat Rev Immunol 2007; 7:443453.
  • 84
    Ehst BD, Ingulli E, Jenkins MK: Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant 2003; 3:13551362.
  • 85
    Rajagopalan S, Long EO: A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999; 189:10931100.